Low-dose intravenous midazolam reduces etomidate-induced myoclonus: A prospective, randomized study in patients undergoing elective cardioversion

Anesthesia and Analgesia

Volumn 105, Issue 5, 2007, Pages 1298-1302

  Hüter, Lars ^a,b   Schreiber, Torsten ^a   Gugel, Michael ^a   Schwarzkopf, Konrad ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA LACTAM ANTIBIOTIC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETOMIDATE; HEPARIN; MAGNESIUM; MIDAZOLAM; PLACEBO; POTASSIUM CHLORIDE;

AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ELECTIVE SURGERY; FEMALE; HEART RATE; HUMAN; LOW DRUG DOSE; MALE; MYOCLONUS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE OXIMETRY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEDATION; SURGICAL PATIENT;

EID: 37349054325     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000287248.25610.c0     Document Type: Article

References (19)

1. Ford SR, Maze M, Gaba DM. A comparison of etomidate and thiopental anesthesia for cardioversion. J Cardiothorac Vasc Anesth 1991;5:563-5
2. Doenicke A, Roizen MF, Nebauer AE, Kugler A, Hoernecke R, Beger-Hintzen H. A comparison of two formulations for etomidate, 2-hydroxypropyl-β- cyclodextrin (HPCD) and propylene glycol. Anesth Analg 1994;79:933-9
3. Hüter L, Schwarzkopf K, Simon M, Bredle D, Fritz H. Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand 2003;47:482-4
4. Berry JM, Merin RG. Etomidate myoclonus and the open globe. Anesth Analg 1989;69:256-9
5. Shulman MS, Edelmann R. Use of etomidate for elective cardioversion. Anesthesiology 1988;68:656
6. van Keulen SG, Burton JH. Myoclonus associated with etomidate for ED procedural sedation and analgesia. Am J Emerg Med 2003;21:556-8
7. Giese JG, Stockham RJ, Stanley TH, Pace NL, Nelissen RH. Etomidate versus thiopental for induction of anesthesia. Anesth Analg 1985;64:871-6
8. Stockham RJ, Stanley TH, Pace NL, Gillmor S, Groen F, Hilkens P. Fentanyl pretreatment modifies anaesthetic induction with etomidate. Anaesth Intens Care 1988;16:171-6
9. Schwarzkopf K, Hüter L, Simon M, Fritz H. Midazolam pretreatment reduces etomidate-induced myoclonic movements. Anaesth Intensive Care 2003;31:18-20
10. Korttila K, Tammisto T, Aromaa U. Comparison of etomidate, in combination with fentanyl or diazepam, with thiopentone as an induction agent for general anaesthesia. Br J Anaesth 1979;51:1151-7
11. Doenicke A, Kugler J, Penzel G, Laub M, Kalmar L, Kilian I, Bezcny H. Hirnfunktion und Toleranzbreite nach Etomidate, einem neuen barbituratfreien i.v. applizierbaren Hypnoticum. Anaesthesist 1973;22:353-66
12. Canessa R, Lema G, Urzua J, Dagnino J, Concha M. Anesthesia for elective cardioversion: a comparison of four anesthetic agents. J Cardiothorac Vasc Anesth 1991;5:566-8
13. Khalil SN, Lawson KS, Hanis CL, Lemak NA, Ruiz RS. Alfentanil decreases myoclonus caused by etomidate. Middle East J Anesthesiol 1999;15:185-92
14. Fassoulaki A, Pateras C, Kaniaris P. Fentanyl in the prevention of etomidate-induced myoclonus. Cah Anesthesiol 1987;35:201-2
15. Kelsaka E, Karakaya D, Sarihasan B, Baris S. Remifentanil pretreatment reduces myoclonus after etomidate. J Clin Anesth 2006;18:83-6
16. Guler A, Satilmis T, Akinci SB, Celebioglu B, Kanbak M. Magnesium sulfate pretreatment reduces myoclonus after etomidate. Anesth Analg 2005;101:705-9
17. Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P. Reducing myoclonus after etomidate. Anesthesiology 1999;90:113-9
18. Kugler J, Doenicke A, Laub M. The EEG after etomidate. Anaesthesiol Resusc 1977;106:31-48
19. Gancher S, Laxer KD, Krieger W. Activation of epileptogenic activity by etomidate. Anesthesiology 1984;61:616-8